Search research articles
Contact Us
Filters
Showing results (131-140 of 351) with videos related to
Page
of 36
Sort By:
Current Opinion in Immunology
|
February 26, 2017
Targeting NK-cell checkpoints for cancer immunotherapy
Aura Muntasell, Maria C Ochoa, Luna Cordeiro, et al.
Experimental Hematology
|
December 17, 2002
Clinical implications of antigen transfer mechanisms from malignant to dendritic cells. exploiting cross-priming
Ainhoa Arina, Iñigo Tirapu, Carlos Alfaro, et al.
Vaccine
|
April 28, 2005
Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus
Laura Arribillaga, Pablo Sarobe, Ainhoa Arina, et al.
Nature Reviews. Clinical Oncology
|
July 9, 2014
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero, Gustav Gaudernack, Winald Gerritsen, et al.
Expert Opinion on Biological Therapy
|
February 16, 2005
Intratumoural administration of dendritic cells: hostile environment and help by gene therapy
Eduardo Huarte, Iñigo Tirapu, Ainhoa Arina, et al.
Neurobiology of Disease
|
September 28, 2007
Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease
Manuel Rodriguez, Lydia Alvarez-Erviti, Francisco J Blesa, et al.
International Review of Cell and Molecular Biology
|
August 14, 2022
Omentum: Friend or foe in ovarian cancer immunotherapy?
Ángela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, et al.
Expert Opinion on Biological Therapy
|
May 5, 2007
Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer
Ainhoa Arina, Oihana Murillo, Juan Dubrot, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 25, 2003
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination
Noelia Casares, Laura Arribillaga, Pablo Sarobe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
Potentiation of therapeutic immune responses against malignancies with monoclonal antibodies
Oihana Murillo, Ainhoa Arina, Iñigo Tirapu, et al.
Page
of 36
Search research articles
Search
Showing results (131-140 of 351) with videos related to
Sort By:
Page
of 36
Current Opinion in Immunology
|
February 26, 2017
Targeting NK-cell checkpoints for cancer immunotherapy
Aura Muntasell, Maria C Ochoa, Luna Cordeiro, et al.
Experimental Hematology
|
December 17, 2002
Clinical implications of antigen transfer mechanisms from malignant to dendritic cells. exploiting cross-priming
Ainhoa Arina, Iñigo Tirapu, Carlos Alfaro, et al.
Vaccine
|
April 28, 2005
Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus
Laura Arribillaga, Pablo Sarobe, Ainhoa Arina, et al.
Nature Reviews. Clinical Oncology
|
July 9, 2014
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero, Gustav Gaudernack, Winald Gerritsen, et al.
Expert Opinion on Biological Therapy
|
February 16, 2005
Intratumoural administration of dendritic cells: hostile environment and help by gene therapy
Eduardo Huarte, Iñigo Tirapu, Ainhoa Arina, et al.
Neurobiology of Disease
|
September 28, 2007
Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease
Manuel Rodriguez, Lydia Alvarez-Erviti, Francisco J Blesa, et al.
International Review of Cell and Molecular Biology
|
August 14, 2022
Omentum: Friend or foe in ovarian cancer immunotherapy?
Ángela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, et al.
Expert Opinion on Biological Therapy
|
May 5, 2007
Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer
Ainhoa Arina, Oihana Murillo, Juan Dubrot, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 25, 2003
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination
Noelia Casares, Laura Arribillaga, Pablo Sarobe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
Potentiation of therapeutic immune responses against malignancies with monoclonal antibodies
Oihana Murillo, Ainhoa Arina, Iñigo Tirapu, et al.
Page
of 36